Notizia - Recent Pharma, Healthcare and Biotech Happenings

Branded product portfolio of Shionogi acquired by Lupin Pharma giant Lupin entered into a strategic agreement when its Japanese subsidiary Kyowa Pharmaceutical Industry Co. purchased the product portfolio of Japan’s Shionogi & Co., Ltd. The agreement results in acquisition of 21 products long-listed, and the deal is said to become effective from December 1, 2016. FDA grants approval to Sanofi’s Adlyxin FDA reviewed results of GetGoal clinical program as well as the outcome of the ELIXA trial of French Company, Sanofi, and granted approval for Adlyxin drug. It is a one-time meal injection as an adjunct therapy to diet and exercise of T2D patients. The GetGoal progra...